# Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19)

> **NCT06360757** · — · TERMINATED · sponsor: **QIAGEN Gaithersburg, Inc** · enrollment: 503 (actual)

## Conditions studied

- SARS-CoV-2 Acute Respiratory Disease

## Interventions

- **DIAGNOSTIC_TEST:** NeuMoDx SARS-CoV-2 Assay

## Key facts

- **NCT ID:** NCT06360757
- **Lead sponsor:** QIAGEN Gaithersburg, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2024-02-06
- **Primary completion:** 2024-07-24
- **Final completion:** 2024-07-24
- **Target enrollment:** 503 (ACTUAL)
- **Why stopped:** Discontinuation of product line
- **Last updated:** 2025-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06360757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06360757, "Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06360757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*